Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Thumbnail

ARBs associated with fewer side effects than ACE inhibitors

Physicians and patients may want to consider selecting ARBs instead of ACE inhibitors as an initial treatment for hypertension, based on a new analysis in Hypertension.

Thumbnail

How a woman’s heart health can affect pregnancy outcomes

According to this new analysis, the risk of pregnancy-related complications increases incrementally with the number of cardiovascular risk factors present before the pregnancy. 

Cleveland Clinic cardiologist shares heart-healthy diet, exercise recommendations

The heart specialist emphasized the importance of plant-based options and warned against eating too many processed foods. 

Thumbnail

FDA pushes for statin warnings to be updated

It has long been believed that patients should not take statins while they are pregnant. Now, however, the FDA is emphasizing that there are certain exceptions to that rule.

Bayer's big news: Finerenone gains FDA approval for patients with chronic kidney disease, type 2 diabetes

The medication is approved for slowing CKD progression in patients with type 2 diabetes. It can also reduce a patient's risk of heart failure hospitalization and cardiovascular death. 

Go fish? Omega-3 fatty acids boost outcomes, reduce cardiovascular mortality

In addition, the team reported, an EPA monotherapy appears to be more beneficial than a mix of EPA and DHA.

Thumbnail

Southern-style diets linked to a higher risk of sudden cardiac death—Mediterranean diet has the opposite effect

Regularly eating a Southern-style diet full of added fats, fried foods, processed meats and sugar-sweetened beverages can do harm to a person's cardiovascular system. 

Thumbnail

Diabetes drug tirzepatide associated with ‘significant improvements’ as Eli Lilly prepares for FDA filing

Full results of the SURPASS-1 clinical trial were presented at the American Diabetes Association’s 81st Scientific Sessions.